These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21066874)

  • 1. [Gelatinases A and B activities in the serum of patients with various coronary artery disease stages].
    Radenković S; Brajović M; Konjević G; Gopcević K
    Vojnosanit Pregl; 2010 Oct; 67(10):825-30. PubMed ID: 21066874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.
    Kai H; Ikeda H; Yasukawa H; Kai M; Seki Y; Kuwahara F; Ueno T; Sugi K; Imaizumi T
    J Am Coll Cardiol; 1998 Aug; 32(2):368-72. PubMed ID: 9708462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
    Fukuda D; Shimada K; Tanaka A; Kusuyama T; Yamashita H; Ehara S; Nakamura Y; Kawarabayashi T; Iida H; Yoshiyama M; Yoshikawa J
    Am J Cardiol; 2006 Jan; 97(2):175-80. PubMed ID: 16442358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion.
    Tanindi A; Sahinarslan A; Elbeg S; Cemri M
    Coron Artery Dis; 2011 Jun; 22(4):253-8. PubMed ID: 21317638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I; Kopczyński Z
    Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of MMP-2 and MMP-9 in sera of breast cancer patients.
    Stankovic S; Konjevic G; Gopcevic K; Jovic V; Inic M; Jurisic V
    Pathol Res Pract; 2010 Apr; 206(4):241-7. PubMed ID: 20092959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
    Jong GP; Wang YF; Tsai FJ; Tsai CH; Wu CL; Liu RH; Hsieh DJ; Ko FY; Huang CY; Lee SD
    Chin J Physiol; 2007 Dec; 50(6):277-82. PubMed ID: 18442010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of matrix metalloproteinases by a whole-cell extract from Prevotella nigrescens.
    Itoh T; Nakamura H; Kishi J; Hayakawa T
    J Endod; 2009 Jan; 35(1):55-9. PubMed ID: 19084125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
    Eckart RE; Uyehara CF; Shry EA; Furgerson JL; Krasuski RA
    J Interv Cardiol; 2004 Feb; 17(1):27-31. PubMed ID: 15009768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
    Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
    Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
    J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum level of carboxy-terminal telopeptide of type I collagen in patients with coronary heart disease].
    Deng Y; Chen LH; Wang XB; Song XD; Ling YN; Chen AH; Yang PZ; Guo JB; Que DD; Chen GM
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):506-10. PubMed ID: 25907933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloproteases 2 and 9, Lp-PLA(2) and lipoprotein profile in coronary patients.
    Muzzio ML; Miksztowicz V; Brites F; Aguilar D; Repetto EM; Wikinski R; Tavella M; Schreier L; Berg GA
    Arch Med Res; 2009 Jan; 40(1):48-53. PubMed ID: 19064127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation.
    Ferroni P; Basili S; Martini F; Cardarello CM; Ceci F; Di Franco M; Bertazzoni G; Gazzaniga PP; Alessandri C
    J Investig Med; 2003 Sep; 51(5):295-300. PubMed ID: 14577520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy.
    Rodrigo E; López-Hoyos M; Escallada R; Fernández-Fresnedo G; Ruiz JC; Piñera C; Cotorruelo JG; Zubimendi JA; de Francisco AL; Arias M
    Nephrol Dial Transplant; 2000 Dec; 15(12):2041-5. PubMed ID: 11096152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.